After turbulent years, Teva CEO Schultz forecasts stability - Israel News - The Jerusalem Post
Teva Pharmaceuticals - Lixoft
Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
Teva Rockets After Hiring Former Novo Nordisk Exec As CEO | Investor's Business Daily
Teva, Allergan settle roles in opioid crisis for $4.25B, $2.37B respectively - Top Class Actions
Teva Reports Fourth Quarter and Full Year 2021 Financial Results | Business Wire
Teva shares plunge as competitors get nod for copycat flagship drug | The Times of Israel
Teva Pharmaceuticals Soars After Buffett's Berkshire Hathaway Discloses Stake
Teva CEO Schultz likely won't renew employment contract: reports
Teva settles with Oklahoma for $85 million in opioid case | PBS News Weekend
Teva reaches $523 million deal to settle opioid lawsuit with New York | CNN Business
Teva made smart decision to move to us: Allergan CEO
Drugmaker Teva latest to settle opioid lawsuits nationally - POLITICO
New York could get $524M under opioid settlements with Teva - ABC News
Teva Pharmaceutical's U.S. Unit Indicted on Price-Fixing Charges - WSJ
Teva CEO: Company Would Have Gone Bankrupt Without Layoffs - Business - Haaretz.com
Allergan, Teva to pay $54M in San Francisco opioid lawsuit | AP News
Teva reaches opioid settlement, Credit Suisse names new CEO, Twitter to hold shareholder vote
Three-Stock Lunch: AMD, HAS & TEVA
Kåre Schultz new CEO of Teva - Nordic Life Science – the leading Nordic life science news service
Teva Settles Arkansas Price-Fixing Case for $931K | Arkansas Business News | ArkansasBusiness.com
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Teva Pharmaceuticals (@TevaUSA) / Twitter
Teva shares surge after announcing global opioid settlement
